Novartis Agrees to $6.8 Billion Medicines Co. Deal

Novartis Agrees to $6.8 Billion Medicines Co. Deal

Assessment

Interactive Video

Business, Biology, Health Sciences

University

Hard

Created by

Quizizz Content

FREE Resource

The video discusses Novartis' strategic expansion through acquiring a company, offering a 45% premium to shareholders. The acquisition is driven by a promising cholesterol drug expected to generate significant sales by 2024. The drug has already tripled the company's shares in anticipation of its success.

Read more

2 questions

Show all answers

1.

OPEN ENDED QUESTION

3 mins • 1 pt

What was the market reaction to the anticipation of the new cholesterol drug?

Evaluate responses using AI:

OFF

2.

OPEN ENDED QUESTION

3 mins • 1 pt

How much revenue is the new drug expected to generate by 2024?

Evaluate responses using AI:

OFF